- Home
- UBSI vs BRKR Comparison
UBSI vs BRKR Comparison
Compare UBSI & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UBSI
- BRKR
- Stock Information
- Founded
- UBSI 1982
- BRKR 1960
- Country
- UBSI United States
- BRKR United States
- Employees
- UBSI N/A
- BRKR N/A
- Industry
- UBSI Major Banks
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- UBSI Finance
- BRKR Industrials
- Exchange
- UBSI Nasdaq
- BRKR Nasdaq
- Market Cap
- UBSI 5.3B
- BRKR 6.3B
- IPO Year
- UBSI N/A
- BRKR 2000
- Fundamental
- Price
- UBSI $38.41
- BRKR $42.13
- Analyst Decision
- UBSI Hold
- BRKR Buy
- Analyst Count
- UBSI 4
- BRKR 12
- Target Price
- UBSI $40.13
- BRKR $54.50
- AVG Volume (30 Days)
- UBSI 905.9K
- BRKR 2.3M
- Earning Date
- UBSI 07-24-2025
- BRKR 08-05-2025
- Dividend Yield
- UBSI 3.85%
- BRKR 0.47%
- EPS Growth
- UBSI 2.88
- BRKR N/A
- EPS
- UBSI 2.70
- BRKR 0.52
- Revenue
- UBSI $1,021,155,000.00
- BRKR $3,446,100,000.00
- Revenue This Year
- UBSI $20.44
- BRKR $6.43
- Revenue Next Year
- UBSI $5.18
- BRKR $4.21
- P/E Ratio
- UBSI $14.25
- BRKR $80.87
- Revenue Growth
- UBSI 0.82
- BRKR 14.84
- 52 Week Low
- UBSI $30.51
- BRKR $34.10
- 52 Week High
- UBSI $44.43
- BRKR $72.94
- Technical
- Relative Strength Index (RSI)
- UBSI 65.26
- BRKR 63.12
- Support Level
- UBSI $36.27
- BRKR $40.71
- Resistance Level
- UBSI $36.88
- BRKR $43.21
- Average True Range (ATR)
- UBSI 0.70
- BRKR 1.70
- MACD
- UBSI 0.22
- BRKR 0.37
- Stochastic Oscillator
- UBSI 99.33
- BRKR 87.46
About UBSI United Bankshares Inc.
United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.